Htlv I & Ii Antibodies

13,000.00

Categories: ,

The HTLV I & II Antibodies test detects antibodies against Human T-cell Lymphotropic Virus Type I (HTLV-I) and Type II (HTLV-II) in the blood. HTLV is a virus that infects T-cells (a type of white blood cell) and is associated with various health conditions, such as HTLV-associated myelopathy (a neurological disorder) and adult T-cell leukemia/lymphoma (ATLL).

• HTLV-I: Most commonly linked with serious conditions like adult T-cell leukemia, HTLV-I associated myelopathy (HAM), and tropical spastic paraparesis.
• HTLV-II: Generally less associated with disease but can sometimes lead to myelopathy and other disorders.

The test detects the presence of antibodies that the immune system produces in response to infection with these viruses. It is important because HTLV infections often go undetected for long periods, as symptoms may not appear until much later in life.

Enquiry Here

    Description

    Why It’s Done:

    The HTLV I & II Antibodies test is performed for several reasons:
    1. Diagnosing HTLV Infection:
    o It helps identify individuals infected with HTLV I or II, even in the absence of symptoms.
    o It is especially useful in individuals with neurological symptoms like weakness, stiffness, or sensory loss (for HTLV-I associated myelopathy).
    2. Assessing Risk for HTLV-Related Conditions:
    o HTLV-I is linked to adult T-cell leukemia/lymphoma (ATLL), a rare cancer of T-cells, and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a neurological condition that affects walking and motor control.
    o The test is important in identifying individuals who may be at higher risk for these diseases, especially if they have a history of exposure to blood products or unprotected sex with someone who has HTLV.
    3. Screening Blood and Organ Donors:
    o It is often performed as part of blood donation screening to prevent the transmission of HTLV through transfusions.
    o It may also be used for organ donors to ensure that recipients do not contract HTLV infections.
    4. Determining the Need for Further Testing or Monitoring:
    o A positive result may lead to further tests to determine the type of HTLV infection (I or II) and whether there are any active disease manifestations (e.g., ATLL or HAM).
    o It can also help with monitoring people who are at higher risk for HTLV-related complications.

    Preparation:

    • No special preparation is required for this test.
    • The test involves a blood sample taken from a vein in your arm.
    • It’s important to inform your healthcare provider about any medications or health conditions you may have, as certain conditions or treatments may impact the immune response.
    • Fasting is not required, but always follow any specific instructions from your healthcare provider if given.